chr9-133424254-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_139027.6(ADAMTS13):c.173-67T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.636 in 1,601,052 control chromosomes in the GnomAD database, including 327,527 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.68 ( 35606 hom., cov: 31)
Exomes 𝑓: 0.63 ( 291921 hom. )
Consequence
ADAMTS13
NM_139027.6 intron
NM_139027.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.60
Publications
19 publications found
Genes affected
ADAMTS13 (HGNC:1366): (ADAM metallopeptidase with thrombospondin type 1 motif 13) This gene encodes a member of a family of proteins containing several distinct regions, including a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF). Defects in this gene are associated with thrombotic thrombocytopenic purpura. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
ADAMTS13 Gene-Disease associations (from GenCC):
- congenital thrombotic thrombocytopenic purpuraInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 9-133424254-T-C is Benign according to our data. Variant chr9-133424254-T-C is described in ClinVar as Benign. ClinVar VariationId is 1221388.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.679 AC: 103067AN: 151806Hom.: 35562 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
103067
AN:
151806
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.631 AC: 914860AN: 1449128Hom.: 291921 AF XY: 0.629 AC XY: 453762AN XY: 721286 show subpopulations
GnomAD4 exome
AF:
AC:
914860
AN:
1449128
Hom.:
AF XY:
AC XY:
453762
AN XY:
721286
show subpopulations
African (AFR)
AF:
AC:
25812
AN:
33384
American (AMR)
AF:
AC:
28571
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
AC:
20032
AN:
26120
East Asian (EAS)
AF:
AC:
33877
AN:
39674
South Asian (SAS)
AF:
AC:
48551
AN:
86132
European-Finnish (FIN)
AF:
AC:
24222
AN:
44184
Middle Eastern (MID)
AF:
AC:
3142
AN:
4164
European-Non Finnish (NFE)
AF:
AC:
691170
AN:
1110660
Other (OTH)
AF:
AC:
39483
AN:
60110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
19489
38978
58467
77956
97445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18592
37184
55776
74368
92960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.679 AC: 103165AN: 151924Hom.: 35606 Cov.: 31 AF XY: 0.676 AC XY: 50188AN XY: 74246 show subpopulations
GnomAD4 genome
AF:
AC:
103165
AN:
151924
Hom.:
Cov.:
31
AF XY:
AC XY:
50188
AN XY:
74246
show subpopulations
African (AFR)
AF:
AC:
32060
AN:
41438
American (AMR)
AF:
AC:
10463
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
2673
AN:
3470
East Asian (EAS)
AF:
AC:
4336
AN:
5126
South Asian (SAS)
AF:
AC:
2721
AN:
4806
European-Finnish (FIN)
AF:
AC:
5921
AN:
10570
Middle Eastern (MID)
AF:
AC:
232
AN:
294
European-Non Finnish (NFE)
AF:
AC:
42608
AN:
67924
Other (OTH)
AF:
AC:
1511
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1644
3289
4933
6578
8222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
808
1616
2424
3232
4040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2479
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.